Therefore, co-targeting both GRP78 and lysosome could be newly suggested to be an attractive anti-cancer therapeutic strategy that provides cancer cells with the worst energy efficiency, based on the mass production of unfolded proteins which cannot be digested. This evidence concerns the gene HSPA5 and cancer.